Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. - Wikidata - wikimedia - TriplyDB

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

http://www.wikidata.org/entity/Q52507854

about

Liver tumors in children with metabolic disorders Development of humanized mouse models to study human malaria parasite infection Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens New horizons for studying human hepatotropic infections Mechanistic inferences from the crystal structure of fumarylacetoacetate hydrolase with a bound phosphorus-based inhibitor Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells A universal system to select gene-modified hepatocytes in vivo Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells Chimeric mouse model for the infection of hepatitis B and C viruses Complete Plasmodium falciparum liver-stage development in liver-chimeric mice.Ploidy reductions in murine fusion-derived hepatocytes.Who needs a liver transplant? (new disease specific indications).Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation.Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice.Hippo pathway activity influences liver cell fate.Liver xeno-repopulation with human hepatocytes in Fah-/-Rag2-/- mice after pharmacological immunosuppression.Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors.Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism.Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.Rescue of lethal hepatic failure by hepatized lymph nodes in mice.Mechanisms of liver injury relevant to pediatric hepatology.The origin and liver repopulating capacity of murine oval cells.Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1.Broadly neutralizing antibodies abrogate established hepatitis C virus infection Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver.Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer.In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.Bone marrow-derived hepatocytes : rare but promising.Kinetics of liver repopulation after bone marrow transplantation.Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion.Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivo Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice

P2860

Q26770292-530CF068-2520-4BD0-B0B8-0C98A3E7B634 Q26851983-98E6999F-6316-4F28-BC7A-1F07FF7A1BCF Q27487009-F675E7D4-B401-4A0F-BB55-B60016A4787C Q27490975-7A4B19B3-6B1D-417D-8E6C-1C0549EA9AC6 Q27629252-5D1D8495-E92C-4397-AFCD-A540EB963012 Q28119001-EBEFDA68-98D1-4751-B611-827E15DC6614 Q28346158-D655AAA1-A7A9-442D-8E71-C2249F20B08D Q28468539-86D2BC32-5102-4048-9A1C-D7F695CA5C04 Q28478987-45AD7133-3D3A-48D0-B471-3BDC3B6D9ADD Q28534370-C64158E4-C379-47E8-91CC-10536833EC19 Q30525395-1ABF0979-D572-49B6-AF29-72C739DA00C6 Q33410782-F59B7514-2577-4259-8AB9-3E182E0569B0 Q33588074-1000ADBD-C78D-4956-9C7D-D4FD72203A42 Q33720308-5DB90FF4-6E7E-443F-A340-0AE6A58D746E Q33756841-F289988D-6D34-44FD-B820-4E136206F7CC Q34060093-907F965D-109B-436E-8AB0-A94F1CB67B27 Q34086937-3E770B33-150B-49C0-8FA6-767C1E1A90E5 Q34090220-8E5F0147-8F07-46D8-BEE0-4FC1CE791E78 Q34142453-78190768-5FD7-4B59-9A89-83EFBB316607 Q34184375-6F05C72E-D32C-4671-9CCC-5B4201C6DADE Q34283083-18D36BBD-D8B6-4AE9-97B1-5678B1F60B2D Q34504973-A8A1BC1D-6016-40ED-8393-0E38B153A257 Q34543378-53CB8EF1-E88A-4F91-AE4E-75958FE5F0F4 Q34559789-CBC8B6F7-CB1E-405D-A023-A82FBA1A98E5 Q34582398-71CE679F-3062-49D3-BD1F-739C7A9D5175 Q34590786-D181904A-EC8C-4298-8577-9B7C467B0D90 Q35032263-B1711873-F643-4FBE-A7D0-B6C8CB64CD70 Q35085099-DAFDD657-08EE-429A-A102-466EB6BF2F6F Q35105022-F33C6232-2E62-4DED-918A-4ECED497CA65 Q35249273-3F030455-5BB9-4C78-84A6-B889F7002701 Q35723184-A8E4844A-32B6-4502-864C-D5DF32A95A5E Q35747548-75C9253A-8674-4038-A22F-CF947D37AD21 Q35747636-3EE1142B-6241-48F4-BB79-B6A47F257ECE Q35764088-CAAE15CF-E3DB-4A12-81EA-A0006C65B069 Q35787953-436411EB-B3F9-410E-B39C-23CAEB82319E Q35829671-AF167D0F-52BB-45DE-9F6F-ADA69CCDB1E6 Q35985007-7658AD4D-73DB-42BD-96F4-7F45EB36AF85 Q36033943-57E5FCFB-7529-4D56-AD66-A94A79A30A49 Q36084471-E6C381BD-2DAB-4519-978C-0D73EEC8B01D Q36115197-5FEB162E-F23C-4D5A-B294-B37BFD84004A

P2860

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.

http://www.wikidata.org/entity/Q52507854

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh-hant

name

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@en

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@nl

type

label

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@en

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@nl

prefLabel

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@en

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@nl

P1433

Q52507854-E4AFFFDE-DC2F-454F-9FEC-07B51CA1C5A0

P1476

Q52507854-25667415-D27D-4281-A924-0F9737C78F77

P2093

Q52507854-6B2AD091-3DDC-439D-9267-5854BF31B76C

Q52507854-74B2E978-BD50-4B8C-AF94-E1D59EB93F13

Q52507854-90A9401E-6587-495D-BA4A-DE58554E2A1F

Q52507854-B10EC523-020C-48F4-ADAD-284F2CFE9EA9

Q52507854-B3EF456F-9E61-4A8F-B974-9AEE7CB9ACB4

Q52507854-CB824051-83A9-45AE-8573-72ACEF07FEA5

Q52507854-E7B64AB8-177B-4A03-964B-2CBA6A49B5C5

P2860

Q52507854-113E7EEF-88AE-4BBA-9D2D-C8E5DDAFE7B0

Q52507854-20F2F479-813C-4251-80B0-A3B2746002BE

Q52507854-5A0FF611-6688-469D-BBED-10AB9F9D4255

Q52507854-7E778F33-69CC-40CC-B3FD-B326CE7EBB40

Q52507854-95473441-511A-4DED-B501-B89788A77917

Q52507854-9A6A379D-A39B-4DCE-AED6-D9D1BAD1AACB

Q52507854-AB6F64A7-C5F4-4626-A132-D8E43297B599

Q52507854-EEFC05D8-43EE-47DA-AA26-B18D0C061076

P2888

Q52507854-C7D6CE54-5BD7-4CC2-918B-3BFEA0599097

P304

Q52507854-A57BA1B3-9998-4C3F-B218-C50858984348

P31

Q52507854-8052C2AD-2A02-4625-B011-2CEBFEC0E768

P356

Q52507854-B7FC56A8-2EBE-4105-9134-B88D43B35823

P407

Q52507854-546AEF04-432F-48EE-90F5-84D5BA42BEE0

P433

Q52507854-4D6CCE8C-582D-4A2F-90D3-5D4E6B13DF92

P478

Q52507854-41545B48-F7A1-463A-959E-4E071C318336

P50

Q52507854-982E7CED-9F10-4D6C-AB26-54D2CA9E3CAA

P577

Q52507854-ED77DBA8-5A9C-4C2E-8C73-5AE65E6C647F

P6179

Q52507854-4A781AFD-A4A4-4EAA-9EF5-3B77CBC23CA2

P698

Q52507854-8F2FA0C0-3E56-4D2A-8C18-D49A953C1C7E

P921

Q52507854-CAAAF1EB-D562-46B0-B00F-8D1059B26454

P356

P1433

Nature Genetics

P1476

Pharmacological correction of ...... ereditary tyrosinaemia type I.

@en

P2093

Finegold M

http://www.w3.org/2001/XMLSchema#string

Kennaway NG

http://www.w3.org/2001/XMLSchema#string

Lindstedt S

http://www.w3.org/2001/XMLSchema#string

Ou CN

http://www.w3.org/2001/XMLSchema#string

Papaconstantinou J

http://www.w3.org/2001/XMLSchema#string

Torres-Ramos CA

http://www.w3.org/2001/XMLSchema#string

al-Dhalimy M

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

raf regulates the postnatal repression of the mouse alpha-fetoprotein gene at the posttranscriptional level

[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

Genetic control of morphogenetic and biochemical differentiation: lethal albino deletions in the mouse.

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat.

Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase.

Molecular characterization of the murine argininosuccinate synthetase locus.

P2888

P304

453-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG0895-453

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

1995-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044553748

http://www.w3.org/2001/XMLSchema#string

P698

7545495

http://www.w3.org/2001/XMLSchema#string

P921